<--- Back to Details
First PageDocument Content
Pharmaceuticals policy / Health / Pharmaceutical industry / Pharmacology / European Medicines Agency / European Union / Marketing authorization / European Directorate for the Quality of Medicines / EudraLex / European Pharmacopoeia / Orphan drug / Supplementary protection certificate
Date: 2015-07-08 04:50:21
Pharmaceuticals policy
Health
Pharmaceutical industry
Pharmacology
European Medicines Agency
European Union
Marketing authorization
European Directorate for the Quality of Medicines
EudraLex
European Pharmacopoeia
Orphan drug
Supplementary protection certificate

emea_strap_url_cmyk_rev_en_std_cent.eps MASTER

Add to Reading List

Source URL: www.hma.eu

Download Document from Source Website

File Size: 535,20 KB

Share Document on Facebook

Similar Documents

PDF Document

DocID: 1xvUb - View Document

PDF Document

DocID: 1xc8R - View Document

Institute of Pharmacology www.pki.unibe.ch Introduction Prof. Dr. Dr. Stephan von Gunten MD PhD MME

Institute of Pharmacology www.pki.unibe.ch Introduction Prof. Dr. Dr. Stephan von Gunten MD PhD MME

DocID: 1vqsj - View Document

Jansone et al.: Intrinsic Activity, 2017; 5 (Suppl.2):A1.6 doi:IA.5.S2-A1.6 published online: 16 October 2017 2nd International Conference in Pharmacology: From Cellular Processes to Drug Targets Rīga, Latvia

Jansone et al.: Intrinsic Activity, 2017; 5 (Suppl.2):A1.6 doi:IA.5.S2-A1.6 published online: 16 October 2017 2nd International Conference in Pharmacology: From Cellular Processes to Drug Targets Rīga, Latvia

DocID: 1vlJU - View Document

Human cells  Notable for research in: -Medecine: Diseases and cancers -Cell Biology -Pharmacology

Human cells Notable for research in: -Medecine: Diseases and cancers -Cell Biology -Pharmacology

DocID: 1vk1K - View Document